menu search

SEM / Select Medical Holdings Corporation (SEM) Q4 2022 Earnings Call Transcript

Select Medical Holdings Corporation (SEM) Q4 2022 Earnings Call Transcript
Select Medical Holdings Corporation (NYSE:SEM ) Q4 2022 Earnings Conference Call February 24, 2023 9:00 AM ET Company Participants Robert Ortenzio - Executive Chairman and Co-Founder Martin Jackson - EVP and CFO Conference Call Participants Justin Bowers - Deutsche Bank Ben Hendrix - RBC Capital Markets Bill Sutherland - Benchmark Company Miles Highsmith - Deutsche Bank Operator Good morning, and thank you for joining us today for Select Medical Holdings Corporation's Earnings Conference Call to discuss the Fourth Quarter 2022 Results and the Company's Business Outlook. Speaking today are the company's Executive Chairman and Co-Founder, Robert Ortenzio; and the company's Executive Vice President and Chief Financial Officer, Martin Jackson. Read More
Posted: Feb 24 2023, 14:52
Author Name: Seeking Alpha
Views: 110725

SEM News  

Select Medical Holdings Deserves A Bullish Outlook Heading Into Earnings

By Seeking Alpha
October 29, 2023

Select Medical Holdings Deserves A Bullish Outlook Heading Into Earnings

Select Medical Holdings has shown strong financial performance, with revenue increasing by 4.9% and net income rising from $104.3 million to $149 mill more_horizontal

Should Value Investors Buy Select Medical (SEM) Stock?

By Zacks Investment Research
October 25, 2023

Should Value Investors Buy Select Medical (SEM) Stock?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Neverthe more_horizontal

Select Medical (SEM) Upgraded to Strong Buy: What Does It Mean for the Stock?

By Zacks Investment Research
October 19, 2023

Select Medical (SEM) Upgraded to Strong Buy: What Does It Mean for the Stock?

Select Medical (SEM) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong more_horizontal

Are Investors Undervaluing Select Medical (SEM) Right Now?

By Zacks Investment Research
September 14, 2023

Are Investors Undervaluing Select Medical (SEM) Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Neverthe more_horizontal

Select Medical (SEM) Up 18% Year to Date: More Room to Run?

By Zacks Investment Research
August 31, 2023

Select Medical (SEM) Up 18% Year to Date: More Room to Run?

Select Medical (SEM) is well-poised for growth on the back of a credible healthcare facility portfolio built through buyouts and JVs coupled with stro more_horizontal

Select Medical (SEM) Q2 Earnings Meet, Revenues Rise Y/Y

By Zacks Investment Research
August 4, 2023

Select Medical (SEM) Q2 Earnings Meet, Revenues Rise Y/Y

Select Medical's (SEM) Q2 results reflect solid segmental revenues, attributable to higher patient days and outpatient visits. Management projects adj more_horizontal

Select Medical (SEM) Up 21% Year to Date: More Room to Run?

By Zacks Investment Research
July 14, 2023

Select Medical (SEM) Up 21% Year to Date: More Room to Run?

Select Medical (SEM) is well-poised for growth on the back of improved patient volumes, an expanding healthcare portfolio and solid cash-generating ab more_horizontal

Select Medical (SEM) Q1 Earnings Top on Improving Profitability

By Zacks Investment Research
May 5, 2023

Select Medical (SEM) Q1 Earnings Top on Improving Profitability

Select Medical (SEM) expects revenues to be within the range of $6.5-$6.7 billion in 2023, indicating a rise of 4.8% from the 2022 figure of $6.3 bill more_horizontal


Search within

Pages Search Results: